Skip to main content

Table 2 SMC outcomes of children and their caregiver by location of residence

From: Urban–rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study

 

URBAN

RURAL

Total

p-value

n

%

n

%

n

%

Receipt of first dose of SPAQ on Day 1

      

< 0.001

 Did not receive SMC drugs

351

7.6

380

5.2

731

6.2

 

 Received SMC drugs

4269

92.4

6880

94.8

11,149

93.8

 

Receipt of first dose of SPAQ under directly observed therapy

      

< 0.001

 No

554

13.0

665

9.7

1,219

10.9

 

 Yes

3715

87.0

6215

90.3

9,930

89.1

 

Receipt of the full 3-day course of SPAQ

      

< 0.001

 No

478

10.3

501

6.9

979

8.2

 

 Yes

4142

89.7

6759

93.1

10,901

91.8

 

Receipt of SMC medicines in all cycles

      

< 0.001

 No

993

21.5

1067

14.7

2,060

17.3

 

 Yes

3627

78.5

6193

85.3

9,820

82.7

 

Knowledge of SMC

      

< 0.001

 Incomplete knowledge

2212

47.9

2941

40.5

5,153

43.4

 

 Complete knowledge

2408

52.1

4319

59.5

6,727

56.6

 

Receipt of SMC medicines by age-ineligible children

      

0.014

 No

852

74.0

1388

77.9

2,240

76.3

 

 Yes

300

26.0

394

22.1

694

23.7

 

Lead mother visit

      

< 0.001

 No

1281

30.0

1672

24.3

2,953

26.5

 

 Yes

2988

70.0

5208

75.7

8,196

73.5

 

Caregiver belief in the protective effect of SMC

      

< 0.001

 No

158

4.3

174

2.9

332

3.4

 

 Yes

3534

95.7

5924

97.1

9,458

96.6